Campath is a medicine used to treat people with B-CLL leukemia for patients that have cancer that has failed to respond to other treatment options. It has not yet been determined if Campath improves symptoms of leukemia or if it helps patients live longer. Campath has not been approved to treat Multiple Sclerosis.
If you have an infection in your body, an immune system problem such as being HIV positive, or have ever had an allergic reaction to Campath, you should not take Campath to treat B-CLL leukemia. Side effects vary depending on how Campath is administered. If it is given via an IV it may cause low blood pressure, shaking, fever, shortness of breath, chills, or a rash. Campath may also weaken the immune system or lower the ability of bone marrow to create blood cells. Some common side effects include shaking, fever, low blood cell counts, nausea, vomiting, rash, tiredness, low blood pressure and itching.
In February 2005, a clinical study was conducted to determine whether or not Campath could be used to help with Multiple Sclerosis. Unfortunately, 3 patients developed severe idiopathic thrombocytopenic purpura (ITP). One of these three individuals died. ITP happens when the body attacks its own blood cells and platelets. Campath has only been approved to treat B-CLL leukemia and has not been approved to treat Multiple Sclerosis.